Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Basal Cell 3Skin Neoplasms 2Neoplasms 2Platinum-Resistant Fallopian Tube Carcinoma 1Neoplasms, Basal Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Meningioma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Basal Cell Nevus Syndrome 1

Interventions

atezolizumab 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Platinum-Resistant Fallopian Tube Carcinoma × HhAntag691 × Clear all
NCT05538091 2025-11-26

Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

University of Pittsburgh

Phase 2 Recruiting
48 enrolled
Gynecologic

Platinum-Resistant Fallopian Tube Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡